209 related articles for article (PubMed ID: 30136129)
1. Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis.
Yeganeh F; Mousavi SMJ; Hosseinzadeh-Sarband S; Ahmadzadeh A; Bahrami-Motlagh H; Hoseini MHM; Sattari M; Sohrabi MR; Pouriran R; Dehghan P
Clin Rheumatol; 2018 Dec; 37(12):3183-3190. PubMed ID: 30136129
[TBL] [Abstract][Full Text] [Related]
2. Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis.
Grujic M; Matic IZ; Crnogorac MD; Velickovic AD; Kolundzija B; Cordero OJ; Juranic Z; Prodanovic S; Zlatanovic M; Babic D; Damjanov N
Clin Chem Lab Med; 2017 Jan; 55(1):73-81. PubMed ID: 27341562
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
[TBL] [Abstract][Full Text] [Related]
4. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.
Buljevic S; Detel D; Pucar LB; Mihelic R; Madarevic T; Sestan B; Varljen J
Rheumatol Int; 2013 Nov; 33(11):2867-74. PubMed ID: 23864142
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis.
Sromova L; Mareckova H; Sedova L; Balaziova E; Sedo A
Clin Chim Acta; 2010 Aug; 411(15-16):1046-50. PubMed ID: 20361950
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity.
Sromova L; Busek P; Sedova L; Sedo A
BMC Musculoskelet Disord; 2015 Sep; 16():244. PubMed ID: 26353808
[TBL] [Abstract][Full Text] [Related]
7. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.
Cordero OJ; Varela-Calviño R; López-González T; Calviño-Sampedro C; Viñuela JE; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; Aspe de la Iglesia B; Pego-Reigosa JM
PLoS One; 2015; 10(7):e0131992. PubMed ID: 26177310
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
[TBL] [Abstract][Full Text] [Related]
9. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
Buljevic S; Detel D; Pugel EP; Varljen J
J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest.
Cordero OJ; Varela-Calviño R; López-González T; Grujic M; Juranic Z; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; de la Iglesia BA; Pego-Reigosa JM
Clin Biochem; 2017 Nov; 50(16-17):903-910. PubMed ID: 28599787
[TBL] [Abstract][Full Text] [Related]
12. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis.
Mavropoulos JC; Cuchacovich M; Llanos C; Aguillón JC; Gatica H; Pizzo SV; Gonzalez-Gronow M
J Rheumatol; 2005 Nov; 32(11):2116-24. PubMed ID: 16265688
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients.
Ragab D; Mobasher S; Shabaan E
Cytokine; 2019 Jan; 113():305-310. PubMed ID: 30077546
[TBL] [Abstract][Full Text] [Related]
15. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders.
Hildebrandt M; Rose M; Mayr C; Arck P; Schüler C; Reutter W; Salama A; Klapp BF
Adv Exp Med Biol; 2000; 477():197-204. PubMed ID: 10849747
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence.
Perner F; Gyuris T; Rákóczy G; Sárváry E; Görög D; Szalay F; Kunos I; Szönyi L; Péterfy M; Takács L
J Lab Clin Med; 1999 Jul; 134(1):56-67. PubMed ID: 10402060
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages.
Hiromura M; Nohtomi K; Mori Y; Kataoka H; Sugano M; Ohnuma K; Kuwata H; Hirano T
Biochem Biophys Res Commun; 2018 Jan; 495(1):223-229. PubMed ID: 29113797
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
